Taylor Hoffman Wealth Management lifted its holdings in UnitedHealth Group Inc (NYSE:UNH) by 146.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,287 shares of the healthcare conglomerate’s stock after buying an additional 1,953 shares during the period. Taylor Hoffman Wealth Management’s holdings in UnitedHealth Group were worth $714,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of UNH. Selective Wealth Management Inc. bought a new position in UnitedHealth Group during the third quarter valued at about $27,000. North Star Investment Management Corp. bought a new position in UnitedHealth Group during the third quarter valued at about $30,000. Delta Asset Management LLC TN raised its holdings in UnitedHealth Group by 111.0% during the third quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 81 shares in the last quarter. Fusion Family Wealth LLC raised its holdings in UnitedHealth Group by 329.7% during the third quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 122 shares in the last quarter. Finally, Massey Quick Simon & CO. LLC raised its holdings in UnitedHealth Group by 212.5% during the third quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock valued at $38,000 after buying an additional 119 shares in the last quarter. 85.66% of the stock is owned by institutional investors and hedge funds.
UNH traded up $0.51 on Friday, hitting $256.97. 2,161,274 shares of the stock traded hands, compared to its average volume of 4,544,972. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $287.94. The company has a current ratio of 0.70, a quick ratio of 0.67 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $237.20 billion, a PE ratio of 19.95, a P/E/G ratio of 1.33 and a beta of 0.61. The business has a fifty day moving average price of $234.76 and a two-hundred day moving average price of $241.05.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.68%. UnitedHealth Group’s dividend payout ratio is 33.54%.
Several research firms have weighed in on UNH. Barclays set a $260.00 target price on UnitedHealth Group and gave the company a “buy” rating in a report on Tuesday, October 8th. Morgan Stanley dropped their price objective on UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating on the stock in a research note on Thursday, September 26th. BMO Capital Markets lowered UnitedHealth Group from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $292.00 to $249.00 in a research note on Monday, September 30th. Cleveland Research reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. Finally, Deutsche Bank began coverage on UnitedHealth Group in a research note on Thursday, September 12th. They issued a “hold” rating and a $263.00 price objective on the stock. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and an average price target of $283.84.
In related news, Director Richard T. Burke sold 2,000 shares of the business’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $231.50, for a total transaction of $463,000.00. Following the transaction, the director now directly owns 187,979 shares in the company, valued at $43,517,138.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, September 17th. The shares were sold at an average price of $232.76, for a total value of $581,900.00. Following the sale, the director now directly owns 187,979 shares in the company, valued at $43,753,992.04. The disclosure for this sale can be found here. Insiders have sold 33,177 shares of company stock worth $7,842,582 over the last 90 days. Corporate insiders own 0.87% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: The benefits and drawbacks of dollar cost averaging
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.